Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic Pain

Recruiting now · Phase 2 · Has a placebo group

Conditions studied: Chemotherapy Induced Neuropathic Pain, Chemotherapy Induced Pain Neuropathy, Chemotherapy Induced Pain

In brief

A randomized study to determine safety and efficacy of a series of subcutaneous (SC) injections of HAL in patients with CINP, compared to matching placebo injections. After that, subjects may have the option to enter an Open Label extension phase, where available, in which all subjects will receive Halneuron.

Key facts

Study ID

NCT06848348

Run by

Dogwood Therapeutics Inc.

People needed

240

Starts

2025-02-21

Expected to finish

2026-08-01

Last updated by the study team

2026-05-29

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients aged ≥18 years.
• Neuropathic pain has been present and is attributed to platinum and/or taxane chemotherapy.
• Patient has received a cancer chemotherapy regimen that included taxanes and/or platinum and has no active or discernible disease progression.

You may not qualify if…

• Current neuropathic pain with symptoms similar to CINP but attributed to causes other than platinum or taxane chemotherapy.
• Patients who have received HAL at any time prior to screening.

Where it is running

• Central Recruiting Site — Sheffield, Alabama, United States (enrolling)
• Central Recruiting Site — Glendale, Arizona, United States (enrolling)
• Central Recruiting Site — Phoenix, Arizona, United States (enrolling)
• Central Recruiting Site — Fair Oaks, California, United States (enrolling)
• Central Recruiting Site — Fountain Valley, California, United States (enrolling)
• Central Recruiting Site — Los Angeles, California, United States (enrolling)
• Central Recruiting Site — Santa Rosa, California, United States (enrolling)
• Central Recruiting Site — Wheat Ridge, Colorado, United States (enrolling)
• Central Recruiting Site — Jacksonville, Florida, United States (enrolling)
• Central Recruiting Site — Jacksonville, Florida, United States (enrolling)
• Central Recruiting Site — Lakeland, Florida, United States (enrolling)
• Central Recruiting Site — Orlando, Florida, United States (enrolling)
• Central Recruiting Site — Port Charlotte, Florida, United States (enrolling)
• Central Recruiting Site — Tampa, Florida, United States (enrolling)
• Central Recruiting Site — Gurnee, Illinois, United States (enrolling)
• Central Recruiting Site — Lake Charles, Louisiana, United States (enrolling)
• Central Recruiting Site — Fenton, Missouri, United States (enrolling)
• Central Recruiting Site — Las Vegas, Nevada, United States (enrolling)
• Central Recruiting Site — Garden City, New York, United States (enrolling)
• Central Recruiting Site — Williamsville, New York, United States (enrolling)
• Central Recruiting Site — Winston-Salem, North Carolina, United States (enrolling)
• Central Recruiting Site — Houston, Texas, United States (enrolling)
• Central Recruiting Site — McAllen, Texas, United States (enrolling)
• Central Recruiting Site — Salt Lake City, Utah, United States (enrolling)
• Central Recruiting Site — Madison, Wisconsin, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.